arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Bodhi Tree Biotechnology Inc

BDTB

— Price unavailable

9 Visible periods

20 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Bodhi Tree Biotechnology Inc faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin -186.2%

ROIC -78.9% ↘

FCF / Share $-0.00 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

9-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$15.00K

— —

Net Income Profit after all expenses

$-29.20K

↑ +45.4% —

Operating Margin Operating profit as % of sales

-186.2%

↓ -109.1% —

FCF / Share Free cash flow per share

$-0.00

↑ +50.9% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 2 metrics

Metric	Q2 FY2026 Mar 31, 2026 10-Q ↗	Q1 FY2026 Dec 31, 2025 10-Q ↗	Q4 FY2025 Sep 30, 2025 10-K ↗	Q3 FY2025 Jun 30, 2025 10-Q ↗	Q2 FY2025 Mar 31, 2025 10-Q ↗	Q1 FY2025 Dec 31, 2024 10-Q ↗	Q4 FY2024 Sep 30, 2024 10-K ↗	Q3 FY2024 Jun 30, 2024 10-Q ↗	Q2 FY2024 Mar 31, 2024 10-Q ↗
Net Income Growth YoY (%)	45.4% Excellent Excellent Year-over-year change in net income	18.3% Good Good Year-over-year change in net income	—	N/M	-45958.6% Weak Weak Year-over-year change in net income	—	—	—	—
FCF Growth YoY (%)	50.9% Excellent Excellent Year-over-year change in free cash flow	5.0% Caution Caution Year-over-year change in free cash flow	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Mar 31, 2026 10-Q ↗	Q1 FY2026 Dec 31, 2025 10-Q ↗	Q4 FY2025 Sep 30, 2025 10-K ↗	Q3 FY2025 Jun 30, 2025 10-Q ↗	Q2 FY2025 Mar 31, 2025 10-Q ↗	Q1 FY2025 Dec 31, 2024 10-Q ↗	Q4 FY2024 Sep 30, 2024 10-K ↗	Q3 FY2024 Jun 30, 2024 10-Q ↗	Q2 FY2024 Mar 31, 2024 10-Q ↗
Operating Margin (%) (%)	-186.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1652%)	—	-89.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-842%)	—	—	—	—	64.9% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+440%)	—
Effective Tax Rate (%) (%)	-4.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-4.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
Profit Margin (%) (%)	-194.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2533%)	—	-89.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1213%)	—	—	—	—	64.9% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+711%)	—
FCF Margin (%) (%)	-164.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-84.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—
FCF / Net Income (x)	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.19x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	-3.31x Weak Weak Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Mar 31, 2026 10-Q ↗	Q1 FY2026 Dec 31, 2025 10-Q ↗	Q4 FY2025 Sep 30, 2025 10-K ↗	Q3 FY2025 Jun 30, 2025 10-Q ↗	Q2 FY2025 Mar 31, 2025 10-Q ↗	Q1 FY2025 Dec 31, 2024 10-Q ↗	Q4 FY2024 Sep 30, 2024 10-K ↗	Q3 FY2024 Jun 30, 2024 10-Q ↗	Q2 FY2024 Mar 31, 2024 10-Q ↗
Return on Invested Capital (%)	-78.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-63.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-35.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	12.9% Good Good Return earned on debt + equity capital invested Optimal: > 10%	-0.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%
Return on Capital (%) (%)	-68.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-76.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-15.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-78.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-626%)	-80.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-633%)	-9.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-160%)	-16.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-207%)	-35.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-336%)	-31.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-312%)	—	16.3% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+9%)	-0.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-102%)

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Mar 31, 2026 10-Q ↗	Q1 FY2026 Dec 31, 2025 10-Q ↗	Q4 FY2025 Sep 30, 2025 10-K ↗	Q3 FY2025 Jun 30, 2025 10-Q ↗	Q2 FY2025 Mar 31, 2025 10-Q ↗	Q1 FY2025 Dec 31, 2024 10-Q ↗	Q4 FY2024 Sep 30, 2024 10-K ↗	Q3 FY2024 Jun 30, 2024 10-Q ↗	Q2 FY2024 Mar 31, 2024 10-Q ↗
Revenue per Share (USD)	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	—
Basic EPS, GAAP (USD)	$0.00	$-0.01	$0.00	$0.00	$0.00	$0.00	—	$0.00	—
Free Cash Flow per Share (USD)	$-0.00	$-0.00	—	$-0.00	$-0.00	$-0.00	—	—	—
Book Value per Share (USD)	$0.00	$0.00	$0.00	$0.01	$0.01	$0.01	$0.01	$0.00	—
Tangible Book Value per Share (USD)	$0.00	$0.00	$0.00	$0.01	$0.01	$0.01	$0.01	$0.00	—
Basic Weighted Avg Shares (shares)	25.44M	25.44M	—	25.44M	25.44M	25.44M	—	16.57M	—

🏦 How resilient is the balance sheet? 1 metrics

Metric	Q2 FY2026 Mar 31, 2026 10-Q ↗	Q1 FY2026 Dec 31, 2025 10-Q ↗	Q4 FY2025 Sep 30, 2025 10-K ↗	Q3 FY2025 Jun 30, 2025 10-Q ↗	Q2 FY2025 Mar 31, 2025 10-Q ↗	Q1 FY2025 Dec 31, 2024 10-Q ↗	Q4 FY2024 Sep 30, 2024 10-K ↗	Q3 FY2024 Jun 30, 2024 10-Q ↗	Q2 FY2024 Mar 31, 2024 10-Q ↗
Total Equity (USD)	$37.02K	$66.21K	$119.16K	$129.85K	$150.62K	$204.05K	$268.83K	$59.61K	$48.38K

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Mar 31, 2026 10-Q ↗	Q1 FY2026 Dec 31, 2025 10-Q ↗	Q4 FY2025 Sep 30, 2025 10-K ↗	Q3 FY2025 Jun 30, 2025 10-Q ↗	Q2 FY2025 Mar 31, 2025 10-Q ↗	Q1 FY2025 Dec 31, 2024 10-Q ↗	Q4 FY2024 Sep 30, 2024 10-K ↗	Q3 FY2024 Jun 30, 2024 10-Q ↗	Q2 FY2024 Mar 31, 2024 10-Q ↗
Sales/Revenue/Turnover (USD)	$15.00K	$0.00	$12.00K	$0.00	$0.00	$5.00K	—	$15.00K	—
Net Income, GAAP (USD)	$-29.20K	$-52.95K	$-10.69K	$-20.77K	$-53.43K	$-64.78K	—	$9.73K	$-116.00
Operating Cash Flow (USD)	$-24.62K	$-62.04K	$-10.11K	$-24.65K	$-50.13K	$-65.28K	—	—	$384.00

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 2 years · 9 quarters

Bodhi Tree Biotechnology Inc

Analytical Summary

9-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BDTB with peers